What Are Totipotent Stem Cells?
Article Jun 11, 2019
Stem cells are characterized according to their degree of potency, which refers to their varying ability to differentiate into different cell types. Totipotent cells are the most potent of all stem cells, and defining them is important for research and the field of regenerative medicine.
Definition of totipotent stem cells
There are two definitions of totipotent stem cells, which reflects the inherent technical difficulty that lies in characterizing them1:
- A totipotent cell is a single cell that can give rise to a new organism, given appropriate maternal support (most stringent definition)
- A totipotent cell is one that can give rise to all extraembryonic tissues, plus all tissues of the body and the germline (less stringent definition)
The original test of totipotency was performed in mice by Tarkowski (1959)2, who isolated a single blastomere (cells created by divisions of the zygote, consisting of 2–16 cells), placed it into an empty zona pellucida, and monitored its development into live born young.
This approach is not bulletproof; the failure of blastomeres to support chimera development may indicate limitations related to the reconstructed embryo, rather than restricted development potential of the cell in question.
It is for this reason that the second, less stringent definition of totipotency is also widely used.
Having two definitions inevitably creates confusion, particularly as the term “totipotency” is often used inappropriately in the literature. It has been argued that this creates unnecessary ethical controversy with practical and political implications.3
Sometimes the term “totipotent” is awarded to cells if they merely participate in an embryonic process – however, this doesn’t mean that they necessarily could give rise to an organism. Other common causes for misclassification include assuming the expression of early embryonic markers to mean totipotency, and taking partial or superficial resemblance to an embryo as evidence for totipotency.3
Totipotent stem cells differ from pluripotent cells, which can differentiate into cells from any of the three germ layers, and multipotent cells which are less potent.
Why the fuss about totipotent stem cells?Totipotent stem cells are unique as they have a greater developmental potential compared with other stem cells. Having the ability to isolate and culture totipotent stem cells creates many therapeutic and research possibilities1 related to:
- Studying zygotic genome activation (the point at which development becomes exclusively controlled by the zygotic genome, rather than the maternal genome)4
- Rewiring the epigenome (treating pathological conditions induced by epigenetic alterations)5
- Understanding early embryonic development in more detail
- Creating human-animal chimeras6 (theoretically, animals with human organs could aid disease modeling, drug development and transplantation)1
Stem cells are increasingly being used as model systems in research. Differentiating between stem cell types relies on an understanding of the embryological roadmaps and the factors that define their pathways.
Source of totipotent stem cellsThe diploid zygote cell is totipotent. Totipotent cells also exist in subsequent divisions of the zygote, before the rise of the trophectoderm lineage (which occurs approximately four days after fertilization, depending on the species).
To understand the origin of totipotent stem cells, it helps to be familiar with the early stages of embryonic development, and the related terminology.
The table below highlights the important stages of early embryonic development and demonstrates the defining point at which totipotent stem cell no longer exist, and pluripotent cells arise.
Major stages of early embryonic development
*To provide a unified developmental chronology of mammalian embryology, the Carnegie Institution for Science developed a set of 23 stages known as the “Carnegie stages” whereby stages are defined by morphological development, and not directly by age or size.
When does a totipotent stem cell change?
|Epiblast||Pluripotent||The epiblast gives rise to the three primary germ layers (ectoderm, endoderm, mesoderm) which will form all somatic lineages plus the germline.|
|Hypoblast||Not pluripotent, not totipotent||The hypoblast gives rise to the extraembryonic primitive endoderm, i.e. the yolk sac which provides nutrients to the embryo when primitive placental circulation has been established.|
|Trophoblast||Not pluripotent, not totipotent||The trophoblast gives rise to various extraembryonic structures which enable implantation into the uterine wall, secrete human chorionic gonadotropin to enable progesterone secretion from the corpus luteum, and form the chorion (fetal part of the placenta).|
GlossaryBlastomere: Cells created by divisions of the zygote, consisting of 2–16 cells
Features of totipotent stem cellsEfforts have been made to establish methods to stabilize or create cells with an expanded developmental potential, relative to established lines of embryonic stem cells.
Through this work, typically in mice, researchers have found a few pieces of the totipotency puzzle.7 This has partly been achieved by analyzing the gene regulatory network that is active at the earliest stages of mammalian embryogenesis, and screening chemicals for their ability to modulate stem cell gene expression.
As it is impractical to assess totipotency in cells using the aforementioned gold standard in every instance (by transferring a blastomere to an empty zona pellucida, transferring it to a mother and seeing if it supports the development and birth of live young), some relevant measures and criteria have been established. These methods are based on characteristics specific to early developmental stages:
Gene expressionGene expression should be characteristic of the appropriate stage of development, e.g.:
- Genes specific to the two-cell stage have been identified in mice (Zscan4, Dux, Eifa, Zfp352, Tcstv1/3, and Tpodz1–5)1
- Totipotent cells should lack the key pluripotency genes (Pou5f1, Sox2, and Nanog have been identified in mice)8
- Oct4, a singular transcription factor, may be indicative of the developmental stage. Oct4 is encoded by POU5F1 and belongs to a family of transcription factors which activate the expression of their target genes. Oct4 is expressed in germ cells, embryonic stem cells and whole embryos, and expression levels vary dramatically during development. A key role for Oct4 in embryogenesis has been identified in several species, including humans.9
Ability to differentiate
Establishment of expanded potential stem cells
Therefore, a term has been coined to describe cells that retain features of totipotent stem cells: expanded potential stem cells (EPSCs).
EPSCs have been established in mice from individual eight-cell blastomeres, and have also been converted from mouse embryonic stem cells and induced pluripotent stem cells.11 This protocol has been described in detail12 and the conversion takes approximately 2–3 weeks in each case.
Characterizing totipotent stem cells presents many challenges, and it remains to be seen whether artificially induced totipotent cells could be maintained in isolation.
However, given that other cell lines can be derived from EPSCs, and the huge potential of regenerative medicine in biotechnology and medicine, it is likely that refining the criteria for totipotency will remain a high priority for the field.
- Baker, C.L., Pera, M.F. (2018). Capturing Totipotent Stem Cells. Cell Stem Cell 22: 25-34
- Tarkowski, A. J. K. (1959). Experiments on the development of isolated blastomeres of mouse eggs. Nature 184: 1286-1287
- Condic, M. L. (2014). Totipotency: What it is and what it is not. Stem Cells and Development 23(8):796-812
- Schier, A. F. (2007). The maternal-zygotic transition: death and birth of RNAs. Science 316: 406-407
- Ferrari, A., et al. (2019). Epigenome modifiers and metabolic rewiring: new frontiers in therapeutics. Pharmacology & Therapeutics 193: 178-193
- Wu, J., et al. (2016). Stem cells and interspecies chimaeras. Nature 540: 51-59
- Yang, Y., et al. (2017). Derivation of pluripotent stem cells with in vivo embryonic and extraembryonic potency. Cell 169: 243-257
- Sharov, A. A., et al. (2008). Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data. BMC Genomics 9: 269
- Fogarty, N. M. E. et al. (2017). Genome editing reveals a role for OCT4 in human embryogenesis. Nature 550:67-73
- Bošković, A., et al. (2014). Higher chromatin mobility supports totipotency and precedes pluripotency in vivo. Genes & Development 28:1042-1047
- Yang, J. et al. (2017). Establishment of mouse expanded potential stem cells. Nature 550: 393-397
- Yang, J., et al. (2019). In vitro establishment of expanded potential stem cells from mouse pre-implantation embryos or embryonic stem cells. Nature Protocols 14: 350-378
As biology presents ever-more challenging targets, the chemistry world is pushing ahead with new tools to design or discover drugs that have optimal kinetics – they bind well to their target, exert the desired effect and have acceptable toxicity profiles. We look at two different approaches being used to explore and optimize the kinetics of tomorrow’s medicines.READ MORE
Francis S. Collins, M.D., Ph.D. Director of the National Institutes of Health, has recently directly addressed the issue of underrepresented groups in science: "Too often, women and members of other groups underrepresented in science are conspicuously missing in the marquee speaking slots at scientific meetings and other high-level conferences.”READ MORE
The infectious agents that continually assault our bodies are many and diverse. Even just a few decades ago, diseases such as smallpox and typhoid were killing millions every year and some still are. Thankfully for us, at least for some diseases, this picture has changed, and the development of vaccines has played a not insignificant role in this achievement.READ MORE